Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Cognitive Impairment, Alzheimer's Disease, and Related Dementias. The company's Alzai Risk Screening Solution offers prevention strategies, timely intervention and diagnosis of diseases. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private insurers. The company was incorporated in 2024 and is based in Toronto, Canada.
Frequently asked questions
What sector does Alzai Health Corp. (ALZI) operate in?
Alzai Health Corp. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Alzai Health Corp. (ALZI) current stock price?
As of the latest data, Alzai Health Corp. stock price is CA$0.36, with a previous close of CA$0.36.
What is Alzai Health Corp. (ALZI) current market capitalization?
Alzai Health Corp. market cap is approximately 22.77 million.
Does Alzai Health Corp. (ALZI) pay dividends?
No. Alzai Health Corp. does not pay a dividend.
What is Alzai Health Corp. (ALZI) beta (volatility) score?
Alzai Health Corp. has a beta of 0.021, indicating lower volatility than the overall market.
